Pharmaceutical | medical industry

With the Pharma & Medical division, founded in 2023, we offer innovative process and production systems specially developed to meet the complex challenges and needs of the pharmaceutical and medical industry.

First of all, our novel method for the inactivation of RNases. This patent-pending approach provides an outstanding, groundbreaking solution for the inhibition of RNases in single-use bioprocess containers, single-use assemblies, and laboratory equipment through non-thermal plasma.

In addition, we supply the industry with pioneering, highly efficient semi- and fully automated production systems for the manufacturing of 2D and 3D single-use bioprocess containers.

Discover the 3CON Pharma | Medical solutions: